Advocates and figures on both sides of the aisle have reacted to the U.S. Supreme Court’s unanimous decision Thursday that pro-life doctors don’t have standing to challenge the U.S. Food and Drug Administration’s approval and regulation of the abortion drug mifepristone.
The Christian Post | RSS